Advertisement

HLA-B51 Frequency in Iranian Patients with Behçet’s Disease

  • F. Shahram
  • F. Davatchi
  • A. Nadji
  • A. Jamshidi
  • K. Bahar
  • M. Akbarian
  • C. Chams
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)

Keywords

Human Leukocyte Antigen Iranian Patient Primary Association Arthritis Foundation Rheumatology Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Davatchi, F., 1998, Behçet’s disease. In Textbook of Clinical Rheumatology (H.S. Howe, and P.H. Feng, eds.), National Arthritis Foundation, Singapore, pp. 298–315.Google Scholar
  2. 2.
    Mizuki, N., and Ohno, S, 1996, Immunogenetic studies of Behçet’s disease. Rev. Rhum. (Engl. Ed.) 63: 520–527.Google Scholar
  3. 3.
    Mizuki, N., Inoko, H., Mizuki, N., et al., 1992, Human leukocyte antigen serologic and DNA typing of Behçet’s disease and its primary association with B51. Invest. Ophthalmol. Vis. Sci. 33: 3332–3340.PubMedGoogle Scholar
  4. 4.
    Mizuki, N., Katsuyama, Y., Yabuki, K.., et al., 2001, HLA class 1 genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet’s disease. Tissue Antigens 57: 457–462.CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • F. Shahram
    • 1
  • F. Davatchi
    • 1
  • A. Nadji
    • 1
  • A. Jamshidi
    • 1
  • K. Bahar
    • 1
  • M. Akbarian
    • 1
  • C. Chams
    • 1
  1. 1.Behçet’s Disease Unit, Rheumatology Research CenterTehran University for Medical Sciences, Shariati HospitalTehranIran

Personalised recommendations